Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma.
about
High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis.A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphomaOutcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.Early relapses in patients with primary CNS lymphoma treated with methotrexate-based chemotherapy without consolidating whole brain irradiation.Efficacy and safety of HD-MTX based systemic chemotherapy regimens: retrospective study of induction therapy for primary central nervous system lymphoma in Chinese.Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment
P2860
Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Rational administration schedu ...... ntral nervous system lymphoma.
@en
type
label
Rational administration schedu ...... ntral nervous system lymphoma.
@en
prefLabel
Rational administration schedu ...... ntral nervous system lymphoma.
@en
P2093
P2860
P1433
P1476
Rational administration schedu ...... ntral nervous system lymphoma.
@en
P2093
A D R Huitema
A J M Ferreri
G Illerhaus
P2860
P304
P356
10.3109/10428194.2012.676177
P577
2012-05-21T00:00:00Z